￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Dosage and usage of sevabertinib-Hyrnuo

2026-02-01 22:25:32

Check Details
Precautions and risk warnings after discontinuation of brigatinib/brigatinib (Embry)

2026-02-01 22:25:32

Check Details
What are the contraindications of ibrutinib/Eco and what should you pay attention to when using it?

2026-02-01 22:25:32

Check Details
Clinical trial status of Ruxolitinib Tablets/Jiekewei

2026-02-01 22:25:32

Check Details
Analysis of possible adverse reactions of Clofazimine

2026-02-01 22:25:32

Check Details
FDA accelerates approval of sevabertinib-Hyrnuo to treat non-squamous non-small cell lung cancer

2026-02-01 22:25:32

Check Details
Reasons Why Doctors May Not Recommend Patients to Use Axitinib (Inlida)

2026-02-01 22:25:32

Check Details
Whether trametinib (Megenin) needs to be taken for a long time and the risks of long-term use

2026-02-01 22:25:32

Check Details
Is Avatrombopag a domestic or imported drug and its market comparison?

2026-02-01 22:25:32

Check Details
Do patients with different types of leukemia need to take giritinib (segatan)?

2026-02-01 22:25:32

Check Details
Whether the hospital can be reimbursed for purchasing Osimertinib (Tagrisso) and the process description

2026-02-01 22:25:32

Check Details
How long does it take to take Eltrombopag (Revlan) before platelets can be significantly increased?

2026-02-01 22:25:32

Check Details
Category
相关知识